These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20510042)

  • 1. [The incidence and risk factors of late-onset non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.].
    Wu T; Liu QF; Zhang Y; Fan ZP; Xu D; Sun J
    Zhonghua Xue Ye Xue Za Zhi; 2010 Apr; 31(4):249-52. PubMed ID: 20510042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation: analysis of 17 cases].
    Xu D; Liu QF; Sun J; Fan ZP; Wei YQ; Zhang Y; Ye CX; Meng FY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):549-53. PubMed ID: 16681886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytomegalovirus infection monitoring in patients with long-term survival after allogeneic hematopoietic stem cell transplantation].
    Chen L; Luo Y; Hu Y; Tan Y; Zhao Y; Fan J; Huang H
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3145-9. PubMed ID: 25573309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation.
    Patriarca F; Skert C; Bonifazi F; Sperotto A; Fili C; Stanzani M; Zaja F; Cerno M; Geromin A; Bandini G; Baccarani M; Fanin R
    Haematologica; 2006 Sep; 91(9):1268-72. PubMed ID: 16956831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of reduced-intensity conditioning and the risk of late-onset non-infectious pulmonary complications in pediatric patients.
    Nagasawa M; Mitsuiki N; Aoki Y; Ono T; Isoda T; Imai K; Takagi M; Kajiwara M; Kanegane H; Morio T
    Eur J Haematol; 2017 Dec; 99(6):525-531. PubMed ID: 28888028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telemetric monitoring of pulmonary function after allogeneic hematopoietic stem cell transplantation.
    Guihot A; Becquemin MH; Couderc LJ; Randrianarivelo O; Rivaud E; Philippe B; Sutton L; Neveu H; Tanguy ML; Vernant JP; Dhédin N
    Transplantation; 2007 Mar; 83(5):554-60. PubMed ID: 17353773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
    Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
    Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
    Urbano-Ispizua A; García-Conde J; Brunet S; Hernández F; Sanz G; Petit J; Bargay J; Figuera A; Rovira M; Solano C; Ojeda E; de la Rubia J; Rozman C
    Haematologica; 1997; 82(6):683-9. PubMed ID: 9499667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation].
    Deng XR; Ren HY; Cen XN; Wang LH; Liang ZY; Wang WS; Qiu ZX; Ou JP; Xu WL; Wang MJ; Li Y; Yin Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):994-8. PubMed ID: 19698246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation.
    Palmas A; Tefferi A; Myers JL; Scott JP; Swensen SJ; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Litzow MR
    Br J Haematol; 1998 Mar; 100(4):680-7. PubMed ID: 9531334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cause of pleuroparenchymal fibroelastosis following allogeneic hematopoietic stem cell transplantation.
    Higo H; Miyahara N; Taniguchi A; Maeda Y; Kiura K
    Respir Investig; 2019 Jul; 57(4):321-324. PubMed ID: 31080050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk Factors and Prognosis of Hepatic cGVHD after Allogeneic Hematopoietic Stem Cell Transplantation].
    Yu D; Han YH; Hu CY; Zhang B; Zhang HX; Li HJ; Qi KM; Cao J; Li ZY; Yan ZL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1174-1179. PubMed ID: 30111426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
    Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.